Sr. Mgr/Assoc. Dir., Marketing Operations

USA (Remote)

Salary Not AvailableSenior Level5+ years exp

Posted 4 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive MLR governance and cross-functional collaboration for regulatory content in a pharma setting, with FDA submissions and Veeva PromoMats admin responsibility.

  • Own MLR oversight and cross-functional meetings to meet content deadlines
  • Must-have: 5+ years in pharmaceutical MLR with strong facilitation
  • Standout: Veeva PromoMats administration, KPI reporting, and 2253 submissions

Job Description

Responsibilities

  • Partner with key internal and external stakeholders across the TG (MS) commercialization team to ensure a collaborative, compliant, and efficient MLR review process
  • Lead the facilitation and organization of our weekly cross functional MLR meetings, ensuring stakeholder and business needs are being addressed according to project timelines
  • Support each stakeholder team with annual MLR forecasting for content approvals across training, marketing, market access and medical affairs
  • Proactively partner with team during offline content reviews to monitor and document progress
  • Manage documentation, clarity and reconciliation of content review and approval comments
  • Plan and manage weekly MLR meeting agendas across the teams to meet content approval needs and deadlines
  • Monitor timelines to ensure pre-meeting documents have been distributed or routed to the MLR review team according to process timeline requirements to support an efficient use of scheduled meeting / review time
  • Facilitate, in partnership with appropriate stakeholders, the delivery of approved materials for Veeva CRM upload, print production, Compliance Wire, etc.
  • Continuously ensure content approvals are following the appropriate review /approval paths and document retention guidelines
  • Prepare and manage 2253 submissions to the FDA, working closely with regulatory and submission vendor

Requirements

  • Associates Degree with 5+ years of relevant MLR career experience within the pharmaceutical industry
  • Strong facilitation and communication skills in managing MLR stakeholder collaboration
  • Expert listening skills and ability to probe for undisclosed information
  • Capable of engaging with senior management and external agency partners
  • Demonstrated experience in successfully supporting brand launches through the MLR process
  • Working knowledge of FDA regulations, pharmaceutical advertising submission guidelines and timelines to facilitate promotional and educational content approvals
  • Highly organized with exceptional attention to detail
  • Experience in working with various MLR technical and organizational tools
  • Experience proofreading technical documents
  • Ability to build, manage, and lead multiple cross-functional partnerships and initiatives simultaneously
    TG Therapeutics logo

    TG Therapeutics

    2.2 Glassdoor

    TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) and from several regulatory agencies outside of the U.S for its therapy as a treatment for relapsing multiple sclerosis. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

    Founded in 2011
    Morrisville, North Carolina, USA
    501 employees (46 in marketing)
    18% recommend to a friend
    43% CEO approval

    Traffic Signals

    Monthly Visitors
    29.4K
    Traffic Source Mix
    Search
    36.1%
    Direct
    48.4%
    Referral
    8.2%
    Social
    5.7%
    Paid
    1.4%

    Headcount Trend

    Current headcount: ~506

    Marketing Team

    Marketing Team Size
    46 (9% of company)

    Funding

    Total Funding
    $455M
    Last Raise
    $250M
    Post IPO Debt, 2 years ago

    Funding History

    • Aug 2024
      Post IPO Debt • $250M
    • Jan 2022
      Post IPO Debt • $70M
    • Dec 2019
      Post IPO Equity • $50M

    Recent News